Pulmonary Arterial Hypertension Clinical Trials

A listing of Pulmonary Arterial Hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 157 clinical trials
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) (RELIEVE-PAH)

The objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, including evidence of initial

hypertension
right ventricular failure
connective tissue disease
  • 0 views
  • 07 Oct, 2022
  • 5 locations
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study (MOVE PAH))

Patients with pulmonary arterial hypertension (PAH) have reduced health related quality of life (HRQOL) and impaired exercise capacity. Despite fourteen approved therapies, most patients die

  • 0 views
  • 14 Oct, 2022
  • 1 location
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) (IMPAHCT)

Pulmonary Arterial Hypertension (PAH). The Phase 2b part of the study will assess three doses to establish an optimal dose for the Phase 3 part of the study. The Phase 2b primary endpoint will be the

  • 0 views
  • 04 Oct, 2022
  • 11 locations
Positioning Imatinib for Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a rare condition in which a narrowing of blood vessels carrying blood through the lungs puts an increased work load on the heart; it has to work harder

  • 0 views
  • 27 Sep, 2021
  • 8 locations
Olaparib for PAH: a Multicenter Clinical Trial (OPTION)

, pulmonary arterial hypertension (PAH), to early-phase clinical trials. We, and others, have published strong evidence that DNA damage accounts for disease progression in PAH and showed that PARP1 inhibition

hypertension
cancer
hysterectomy
pulmonary disease
body mass index
  • 22 views
  • 09 Jun, 2022
  • 3 locations
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH (TYEGER)

Pulmonary arterial hypertension (PAH) is a disease characterized by elevated pressures in the blood vessels of the lungs that is not caused by another disease processes. More specifically, it is

hypertension
right heart catheterization
vascular disease
hpah
Accepts healthy volunteers
  • 0 views
  • 23 Mar, 2022
  • 1 location
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension (FONCE-HTAP)

Pulmonary Arterial Hypertension is characterized by a progressive increase in pulmonary vascular resistance inducing shortness of breath and exercise intolerance. We aim to correlate cardiac

hypertension
  • 7 views
  • 23 Mar, 2022
  • 9 locations
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

This is a Phase 2, parallel group study to evaluate the safety, tolerability, PK, and exploratory efficacy of 3 doses of CS1 in the treatment of PAH using the CardioMEMS HF System to obtain

  • 0 views
  • 25 May, 2022
  • 1 location
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension

A Randomized, Placebo-Controlled, Double-blind, Dose Escalation Study to Assess Safety, Efficacy and Pharmacokinetics of GMA301 Injection in Subjects with Pulmonary Arterial Hypertension

right heart catheterization
walk tests
pulmonary arterial pressure
diuretics
connective tissue disease
  • 0 views
  • 25 Mar, 2022
  • 5 locations
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study (VIPAH-PRN 2B)

pulmonary arterial hypertension (PAH).

right heart catheterization
cpet
left ventricular end-diastolic pressure
calcium channel blockers
forced expiratory volume
  • 0 views
  • 07 Oct, 2022
  • 14 locations